Ette EI, Fadiran EO, Missling C, Hammond E. The new big is small: Leveraging knowledge from small trials for rare disease drug development: Blarcamesine for Rett syndrome. Br J Clin Pharmacol. 2023 Jul 10; PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Blarcamesine